Forensic Analysis · Technology / Software · as of Aug 10, 2026

Red Violet, Inc. (RDVT)

A forensic read on Red Violet, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

B · Sound & dependable

Forensic grade

Safe

Financial health

16.6

Distress distance

Clean

Earnings quality

Forensic signals

66.4

P / E (ttm)

13.0%

ROE

$914M

Market cap

0.00%

Dividend yield

20.0%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Red Violet, Inc. earns a B (Sound & dependable) forensic quality grade, and its balance-sheet distress test reads 16.6, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of noa).

What the filings flag

+13.5%

FY2024→FY2025

Accruals ratio (% of NOA). Net operating assets grew +13.5% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by receivables up +33% against revenue +20%. The cash-flow cross-check is more mixed: reported earnings ran behind operating cash by 30% of net operating assets, diverging from the balance-sheet accrual read.

+0.7%/yr

FY2022–FY2025

Share count. Diluted share count changed +2% over the last 3 years to FY2025 (+0.7%/yr). Roughly flat — buybacks ($915,000) are about offsetting stock comp ($6M), not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.

Key fundamentals

Latest Revenue$90.3M

Revenue Growth YoY+20.0%

Revenue CAGR (3yr)+19.2%

Net Margin14.6%

Free Cash Flow$28.8M

Return on Equity13.0%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Red Violet, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 10, 2026. Forensic signals flag probability, not certainty.